LifeMD, Inc. — Director's Dealing 2017

Nov 13, 2017

SEC Form 3/A — Form 3/A

Issuer: Immudyne, Inc. (IMMD)
CIK: 0000948320
Period of Report: 2017-10-16

Reporting Person: McLaughlin Mark (Director, Chief Executive Officer, 10% Owner)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock, par value $0.01	3770943	Direct
Common Stock, par value $0.01	1140000	Indirect
Common Stock, par value $0.01	244228	Indirect
Common Stock, par value $0.01	729675	Indirect
Common Stock, par value $0.01	770675	Indirect
Common Stock, par value $0.01	755753	Indirect
Common Stock, par value $0.01	852175	Indirect

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Option	$0.2	2022-10-11	Common Stock, par value $0.01 (1800000)		Direct
Option	$0.4	2022-10-11	Common Stock, par value $0.01 (500000)		Direct
Option	$0.4	2027-01-01	Common Stock, par value $0.01 (500000)		Direct
Option	$0.35	2027-06-30	Common Stock, par value $0.01 (250000)		Direct
Option	$0.2	2021-04-19	Common Stock, par value $0.01 (200000)		Indirect
Option	$0.4	2027-01-01	Common Stock, par value $0.01 (100000)		Indirect
Option	$0.35	2027-06-30	Common Stock, par value $0.01 (75000)		Indirect

Footnotes

F1: The Reporting Person beneficially owns shares through a company owned together with his spouse.

F2: The Reporting Person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose.